What's breaking now, across thousands of outlets.
The drop is a sharp reversal of a massive 2026 stock rally fueled by optimism over its personalized cancer vaccine.
We haven't written up this one. Forbes has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
(MedPage Today) -- PHOENIX -- Sustained breath holding while taking lung nodule biopsies by robotic bronchoscopy didn't improve diagnostic yield, a small randomized trial showed.
Royal Bank of Canada’s capital markets division named Sara Mahaffy as head of Canadian equity strategy, marking the first time in a decade it’s had a dedicated strategist covering the domestic stock…
